Tag: Investment in healthcare

bluebird-bio-sold-to-carlyle-sk-capital-for-under-30m

Bluebird Bio Sold to Carlyle, SK Capital for Under $30M

Bluebird Bio, a once-promising biotech company, made headlines recently with its decision to sell itself and its portfolio of gene therapies to investment firms...

BREAKING NEWS

Top News